Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Edan Instruments

EDAN Instruments manufactures and distributes diagnostic medical equipments in the areas of obstetrics & gynecology, ... read more Featured Products: More products

Download Mobile App





Edan Debuts Next-Gen Blood Gas & Chemistry Analyzer and Patient Monitor at MEDICA 2021

By LabMedica International staff writers
Posted on 17 Nov 2021

EDAN Instruments, Inc. More...

(Shenzhen, China) introduced five new products that are aimed at improving caregiver efficacy and resource accessibility at MEDICA 2021.

Three ready-to-launch products from EDAN, namely its next-gen blood gas and chemistry analysis system i20, 3rd Generation patient monitor iX Series, and the integrated portable version biofeedback and stimulation system PA4 Pro made their debut at MEDICA 2021. EDAN also highlighted its recently-introduced paperless tablet ECG machine iSE and 5-part auto hematology analyzer H60s.

EDAN’s iSE series 12/18 lead ECG machine features an outstanding tablet design and is intended to bring exceptional mobile experience and build a seamless connection to IT systems. It is suitable for applications such as ambulance or first-aid, as well as modern paperless informationized hospitals. Weighing less than one kg, it can start sampling automatically once all lead cables are connected and the desired signal quality is achieved. Its innovative self-adaptive AC filter technology ensures more desirable ECG signal quality in real clinical settings, especially under extreme environments with unstable voltage.

"The products we present this time is mind-changing," said EDAN's Senior Director of Global Marketing and Strategic Operations, Alex You. "In healthcare, efficacy speaks volumes about how technologies make a positive impact on paramedics' workflow, and further save time for patient interaction and more. On iSE, you can have a glance at our plan in IoMT. Intelligent healthcare and IoT-enabled devices have been our focus in recent years. We believe med-tech can improve patient care, and IoT can make this one step further."

"EDAN remains committed to improving people's lives by providing value-driven, user-centered products. The needs are continually evolving. And that's our job to adapt to it and continually optimize our products for the market," added Hao Zhang, CEO of EDAN. "Our mission is to make caregivers' work easier so that they could do more for patients. And the product we present this time just speaks for it."

Related Links:
EDAN Instruments, Inc. 


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.